您好,欢迎来到筏尚旅游网。
搜索
您的当前位置:首页参考文献

参考文献

来源:筏尚旅游网


[1] Suh, S.J., et al., Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res, 2007. 21(2): p.135-41.

[2] Jiangsu New Medical College, Dictionary of Chinese MateriaMedical. Shanghai: Science and Technolo gy Press of Shan ghai, 1977.

[3] Qian B, Clinical-Effects of Anticanter Chinese Medicine. Shanghai: Translation Publishing House, 1987.6-7.

[4] Yin X L, Zhou J B, Jie CF, Anticancer activity and mechanism of Scutellaria barbata extract on human lun g cancer cell line A549[J]. Life Sci, 2004, 75: 2233-2244.

[5] 宋立人,洪询,丁绪亮,等.现代中药大辞典.人民卫生出版社,2001.

[6] Wong,B.Y.,Lua,B.H.,Yuan,J.T.,et al.. Oldenlandia diffusa and batbata allgment maerophage exidetive burst inhibit tumor growth. Cancer Biother.Radiopharm.,1996,11(1):51-56.

[7] Chen, V., et al., Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS. PLoS One, 2012. 7(2):p.e30300.

[8] Chen, V.,et al.,Identification and analysis of the active phytochemicals from the anti-cancer botanical extract Bezielle. PLoS One,2012.7(1): p.e30107.

[9] 郭丽华等, 半枝莲黄酮类单体对人卵巢癌SKOV3细胞增殖的影响. 上海中医药杂

志, 2013(01): 第61-65页.

[10] 叶华等, 半枝莲多糖对C26荷瘤小鼠血清Th1/Th2亚群细胞因子的影响. 癌症进展, 2013(01): 第68-70+81页.

[11] 张自丽, 张雪薇与宋高臣, 半枝莲多糖对S_(180)肉瘤转移抑制作用的研究. 牡丹江医学院学报, 2013(02): 第25-27页.

[12] 陈爱东, 朱正日与陈东麟, 半枝莲多糖对小鼠胃癌模型中P21和VEGF表达的影响. 中国药物经济学, 2013(06): 第296-297页.

[13] 张晶与赵伟杰, 半枝莲多糖对S180荷瘤小鼠红细胞功能的影响. 中国实验方剂学杂志, 2013(22): 第265-268页.

[14] 杨姗姗与张秀娟, 半枝莲多糖对S_(180)荷瘤小鼠脾淋巴细胞内Ca2+浓度的影响. 西南农业学报, 2013(06): 第2610-2613页.

[15] 杨姗姗, 木艳与张秀娟, 半枝莲多糖的纯化及对S(180)小鼠体内抗肿瘤的作用. 江苏农业科学, 2012(5): 第249-251页.

[16] 杨姗姗, 吴大军与张秀娟, 半枝莲多糖的纯化及抗肿瘤作用的体内实验研究.江西农业大学学报, 2012(2): 第392-396页.

[17] 叶华等,半枝莲多糖对C26荷瘤小鼠caspase-3,8,9活性的影响. 中国老年学杂志, 2012(23): 第5152-5153页.

[18] 刘佳维等, 半枝莲多糖对肝癌细胞SMMC7721生长抑制及机制的研究. 广州中医药大学学报, 2012(6):第695-698页.

[19] 赵杰等, 半枝莲多糖对四氯化碳致小鼠肝损伤保护作用的研究.中国中医药科技, 2012(1).

[20] 曾秋红,半枝莲黄酮类化合物体外抗肿瘤活性的研究. 海峡药学, 2011(1): 第137-139页. 王笑娜, 半枝莲黄酮化合物调控胃癌细胞Survivin、PTEN蛋白表达的实验研究, 2010, 扬州大学.

[21] 李中华, 涂燕云与赵晓芳,半枝莲总黄酮对肝纤维化大鼠血清白介素-10表达的影响. 中药药理与临床, 2010(2): 第44-46页.

[22] 韩玉英, 文朝阳. 抗癌中草药研究进展[J]. 北京中医杂志, 2003, 22 (2) : 45.

[23] 汪红, 王强, 余国奠. 近十年抗肿瘤中药的研究进展[J]. 中国野生植物资源, 1999, 19 (3) :7 - 10.

[24] 邹夏慧, 张琨和. 中药抗肿瘤作用分子机制研究进展[J]. 国外医学肿瘤学分册, 2005, 32(1) : 17 - 19.

[25] Turk T, Mancini I, Sepi K , etc. 3-Akylpyridinium and 3-alkylpyridine compounds from marine spon ges, their synthesis, biological activities and potential use[J]. Studies in Natural Products Chemistry, 2008, 35: 355-397.

[26] Mayer MS, Kirk R. Gustafson Alejandro, Marine pharmacolo gy in 2001-2:

antitumour and cytotoxic compounds[J]. European Journal of Cancer, 2004, 18(40): 2676-2704.

[27] Oberlies N H, Corbett T H, Jones J L, etc.Tumor cell growth inhibition byseveral Annonaceous aceto genins in an in vitro disk diffusion assay[J]. Cancer Letters, 1995, 14(96): 55-62.

[28] Suh, S.J., et al., Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res, 2007. 21(2): p.135-41.

[29] 赵学敏.本草纲目拾遗(第一版).北京:北京人民卫生出版社,1983.148.

[30] 侯宽昭.广州植物志.北京:科学出版社,1956:132.

[31] 贾祖璋,贾祖珊.中国植物图鉴.北京:中华书局股份有限公司,1957,20:855

[32] 中国医学科学院药用植物所.中药志.第4册.北京:人民卫生出版社,1988:302-306

[33] 清•赵学敏,本草纲目拾遗.北京:人民卫生出版社,1963:85,88-89,148-151.

[34] 国家药典委员会.中华人民共和国药典[ M ] .北京 北京化学工业出版社,2005 :77.

[35] 陈泽雄,张诗军,陈雯.中药复方对人肿瘤细胞凋亡及增殖影响的实验研究[J].中药材,2000,23(8):477

[36] 陈泽雄,陈雯,彭俊生,等.中药抗癌方抑制人结肠癌细胞株端粒酶活性[耳]中国胃肠外科杂志,1999,2(2):117

[37] 中华人民共和国卫生部国家药典委员会 编.中国药典(1977年版一部)[S].北京:人民卫生出版社,1978:189-189.

[38] 中华人民共和国卫生部国家药典委员会 编.中国药典(1985年版一部)[S].北京:人民卫生出版社 化学工业出版社,1985:93-94.

[39] 国家药典委员会 编.中国药典(2000年版一部)[S].北京:化学工业出版社,2000:89-89.

[40] 李萍, 半枝莲化学成分研究Ⅱ:[硕士学位论文]. 沈阳:沈阳药科大学, 2008.

[41] 王文蜀, 周亚伟. 半枝莲中黄酮类化学成分研究[J]. 中国中药杂志,2004,29(10): 957 -958.

[42] 余群英, 戴胜军, 张德武. 半枝莲化学成分的分离与鉴定[J]. 中国现代药,2011, 1(2): 25-28.

[43] 张祎, 何枢衡. 半枝莲化学成分的分离与鉴定 Ⅱ [J].沈阳药科大学学报, 2011, 26 (6):425-428.

[44] 曹雷, 高继伟. 半枝莲中小分子成分及药用价值综述[J]. 长春师范学院学报, 2009, 28(4): 46-50.

[45] 邹箴蕾, 吴启南. 半枝莲的化学成分及药理作用研究进展[J]. 时珍国医国药, 2005, 16(2): 149-150.

[46] 邹箴蕾. 半枝莲不同药用部位总黄酮含量测定[J]. 广西中医学院学报, 2004, 7(3): 72-73.

[47] Lin Y L, Kuo Y, Scutellone A. A novel diterpene from Scutellaria rivularis [J]. Journal of Chemical Research, Synopses. 1987, 10:320-323.

[48] Lin Y L, Yueh H. Four new neoclerodantype diterenoids, ScutelloneB, G, H and I, from aerial parts of Scutellariarivularis [J]. Chem.Pharm.Bull, 1989, 37(3): 581-585.

[49] Lin Y L, Yueh H. Scutellone C and F, two new neoclerodantype diterenoids from Scutellaria rivularis [J]. Heteroeyles, 1988, 27(3): 778-783.

[50] Lin Y L, Yueh H, Min g C. Structures of Seutellones D and E determined from X-ray diffraction, Spectral and chemical evidence, neoclerodanetype diterpenoids from Seutellaria rivularis Wall[J]. Chem.Pharm.Bull, 1988, 36(7): 2641-2646.

[51] Haruhisa K, Yoshitaka l, Structures of Neoclerodanetype diterpenoids from the Whole herb of Scutellaria rivularis Wall[J]. Chem.Pharm.Bull, 1997, 45(l): 152-160.

[52] Tohru K, Koji T, Shigetoshi K, New clerodanetype diterpenoide from scutellaria rivularis Wall[J]. Chemistry Letters,1987: 987-999.

[53] ZhuP Y, Liu G Q. Isolation and identification of the diterpenoid and flavones in Scutellaria barbata D.Don[J].植物资源与环境, 1993,2(4):63-64.

[54] Torre M C, Rodriguez B, Bruno M. Neoclerodane diterpenoids from Scutellaria polyodon. J Nat Prod, 1997, 60:1229-1235.

[55] Lee H, Kim Y J, Choi I. Two novel neo-clerodane diterpenoids from Scutellaria barbata[J] Bioor ganic & Medicinal Chemistry Letters, 2010, 20:288-290.

[56] Zhu F, Di Y T, Liu L L. Cytotoxic Neoclerodane Diterpenoids from Scutellaria barbata[J]. J.Nat. Prod, 2010, 73: 233-236.

[57] Lee H, Shim S H, neo - Clerodane Diterpenoids from the Aerial Part of Scutellaria barbata[J].Helvetica Chimica Acta, 2011,94:643-649.

[58] Dai S J, Tao J Y, Liu K, neo-Clerodane diterpenoids from Scutellaria barbata with cytotoxic activities[J]. Phytochemistry, 2006, 67: 1326-1330.

[59] Dai S J, Qu G W, Qun - Yin g Yu. New neo-clerodane diterpenoids from Scutellaria barbata with cytotoxic activities [J]. Fitoterapia, 2010, 81: 737–741.

[60] 朱锋, 刘玲丽, 邸迎彤, 等. 半枝莲的一个新的克罗烷二萜[J]. 云南植物研究, 2009,31(5): 474-476.

[61] Baldomero E, Rosa M D, R. A. T.Neoclerodane Diterpenoids from Scutellaria caerulea[J]. J.Nat. Prod, 2001, 64: 778-782.

[62] Dai S J, Shen L, Ren Y.Two new neo-clerodane diterpenoids from Scutellaria barbata[J].Journal of Integrative Plant Biology, 2008, 50(6): 699-702.

[63] Lee H, Kim Y J, Choi I. Two novel neo-clerodane diterpenoids from Scutellaria barbata[J] Bioor ganic & Medicinal Chemistry Letters, 2010, 20:288-290.

[64] N guyen VH, Pham VC, N guyen TTH, Novel Antioxidant neo-Clerodane Diterpenoids from Scutellaria barbata[J]. Eur.J.Org.Chem,2009: 5810-5815.

[65] Zhu F, Di Y T, Liu L L. Cytotoxic Neoclerodane Diterpenoids from Scutellaria barbata[J]. J.Nat. Prod, 2010, 73: 233-236.

[66] Dai S J, Liang D D, Ren Y. New neo-Clerodane Diterpenoid Alkaloids from Scutellaria barbata with Cytotoxic Activities[J]. Chem. Pharm. Bull, 2008, 56(2): 207-209.

[67] Wang F, Ren F C, Li Y G. Scutebarbatines W-Z, New neo-Clerodane Diterpenoids from Scutellariabarbata and Structure Revision of a Series of 13-Spiro neo-Clerodanes[J]. Chem. Pharm.Bull, 2010, 58(9): 1267-1270.

[68] Dai S J, Wang G F, Chen M, Liu K, Shen L, new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities[J]. Chem Pharm Bull,

2007, 55: 1218-1221.

[69] Lee H, Shim S H, neo - Clerodane Diterpenoids from the Aerial Part of Scutellaria barbata[J].Helvetica Chimica Acta, 2011, 94: 643-649.

[70] Dai S J, Peng W B, Zhang D W, Cytotoxic neo-Clerodane Diterpenoid Alkaloids from Scutellaria barbata [J]. J Nat Prod, 2009, 72: 1793–1797.

[71] Zhu F, Di Y L, Li X X. Neoclerodane Diterpenoids from Scutellaria barbata[J]. Planta Med,2011, 77: 1536–1541.

[72] Nie X P, Qu G W, Yu X D. Scutelinquanines A-C, three new cytotoxic neo-clerodane diterpenoid from Scutellaria barbata [J]. Phytochemistry Letters, 2010, 3:190–193.

[73] Dai S J, Qu G W, Qun-Ying Yu. New neo-clerodane diterpenoids from Scutellaria barbata with cytotoxic activities [J]. Fitoterapia, 2010, 81: 737-741.

[74] Lee H, Kim Y, Choi I, Min B S, Shim SH. Two novel neoclerodane diterpenoids from Scutellaria barbata[J]. Med Chem Lett, 2010, 20: 288–290.

[75] Dai, S J, Wang G F, Chen M. Five new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities[J]. Pharmaceutical Bulletin, 2007, 55(8): 1218-1221.

[76] 许益民, 郭立玮, 陈建伟. 半枝莲多糖的分离纯化及其理化性质[J]. 天然产物研

究与开发, 1992, 4(1):1.

[77] 孟延发, 李志孝, 工秉峰, 等. 半枝莲多糖的研究[J]. 兰州大学学报:自然科学版, 1992,28(4):112.

[78] 王志远, 戴玲, 朱业云, 等. 半枝莲酸性多糖SBPs的纯化性质及抗氧化活性研究[J]. 中草药, 2009, 40(5): 728-731.

[79] 杨顺利. 正交试验优选半枝莲超临界二氧化碳萃取条件研究[J]. 解放军药学学报, 2004,20(1): 46-48.

[80] 邱佳, 秦民坚, 唐楠. 半枝莲地上部分的化学成分[J]. 植物资源与环境学报, 2009,18(1): 91-93.

[81] 王兆玉,汪铁山,陈飞龙. 半枝莲全草挥发油的 GC-MS分析[J].南方医科大学学报,2009,29(7):1482-1483.

[82] 陈燕, 张国刚. 半枝莲的化学成分研究Ⅰ[J]. 中国药物化学杂志, 2008: 48 - 50.

[83] 李宁, 肖海涛, 孟大利. 半枝莲的化学成分[J]. 中国现代中药, 2009, 11(12): 16-20.

[84] 李萍, 左甜甜, 张国刚. 半枝莲的化学成分[J]. 沈阳药科大学学报, 2008, 25(7): 549-552.

[85] 余群英, 戴胜军, 张德武. 半枝莲化学成分的分离与鉴定[J]. 中国现代药, 2011,

1(2): 25-28.

[86] 席荣英, 李聪辉, 王翠红. 半枝莲微量元素含量的测定[J]. 微量元素与健康研究, 2002,19 (2): 37.

[87] 邹箴蕾. 半枝莲不同药用部位总黄酮含量测定[J]. 广西中医学院学报, 2004, 7(3): 72-73.

[88] Dai S J,Peng W B,Zhang D W,Shen L,Wang W Y,Ren Y.J Nat Prod,2009,72:1793.

[89] Dai S J,Chen M,Liu K,Jiang Y T,Shen L.Chem Pharm Bull,2006,54:869.

[90] Dai S J,Wang G F, Chen M, Liu K, Chem Pharm Bull,2007,55:1218.

[91] Dai S J,Sun J Y,Ren Y,Liu K,Shen L.Planta Med,2007,73:1217.

[92] Dai S J,Liang D D, Ren Y, Shen L. Chem Pharm Bull,2008,56:207.

[93] Dai S J, Peng W B, Shen L, Zhang D W, Ren Y.J Asian Nat Prod Res,2009,11:451.

[94] 曲桂武, 安徽半枝莲中新克罗烷型二萜化合物的发现及抗肿瘤活性研究, 2012, 中国海洋大学. 第 185页.

[95] 徐任生. 天然产物化学[M]. 第二版. 北京:科学出版社,2010:345-350.

[96] 魏顺发, 屈爱桃, 任凤霞, 等. 黄芩属植物中二萜类成分研究进展[J]. 国际药学研究杂志, 2011, 38(2):123-129.

[97] Jones W P,Lobo-Echeverri T,Mi Q,Chai H B,Soejarto D D,Cordell G A,Swanson S M,Kinghorn A D.J Nat Prod,2007,70:372.

[98] Oberlies N H,Burgess J P,Navarro H A,Pinos R E,Fairchild C R,Peterson R W,Soejarto D D,Farnsworth N R,Kinghorn A D, Wani M C,Wall M E .J Nat Prod,2002,65:95.

[99] Rowinsky EK,Cazenave LA,Donehower R C.Taxol:a nove linvestigational antimicrotuble agent.J Natl Caneer Inst,1990,15:1247-1259.

[100] 刘义,吴育廉,邓亦峰,梁念慈.半边旗提取物SF体外对猪脑微管蛋白聚合的影响.中国药理学通报.2005,4:447-449.

[101] Wang L,Zhao W L,Yan JS,etal.ErioealyxinB induees apoptosis of t(8:21)leukemia cells through NF-kaPPaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a easpase-3-dependent manner.Cell Death Differ,2007,14:306-317.

[102] Leung CH, Grill SP, Lam W,et al. Erioca1yxin B Inhibits Nuclear Faetor-{kappa}B Aetivation by Interfering with the Binding of Both P65 and P5O to the ResPonse Element in a Noneompetitive Manner. Mol Pharmaeol, 2006,6:1946-1955.

[103] 刘加军,李桥,潘祥林等.冬凌草甲素对白血病NB4细胞的诱导凋亡作用及其机制。中草药,2005,8:1188-1193.

[104] Zhang CL,Wu LJ,Tashiro S,et al.Oridonin Induced A375-52 Cell Apoptosis via Bax-regulated Caspase Pathway Activation, Dependent on the Cytochrome c/caspase-9 apoptosome.J Asian Nat Prod Res,2004,2:127-138.

[105] Zhou J,ZhangS ,Ong CN.,et al. Critical role of pro-apoptotic Bel-2 family members in and rograPholide-induced apoptosis in human cancer cells Bioehem Pharmacol. 2006, 2:132-44.

[106] Bhalla K,Ibrado AM,Tourkina E,et al.Taxol induces internucleosomal DNA

Fragmentation associated with programmed cell death in human myeloid leukemia cell.Leukemia,1993,4:563-568.

[107] Donaldson KL,Godlsby G, Kiener DA,et al. Aetivation of p34edc2 coineident with taxolinduced apoptosis.Cell Growth Differ,1994,10:1041-1050.

[108] 郭娟娟,潘长林,冯长伟等.冬凌草甲素诱导多药耐药细胞系K562/A02凋亡、逆转耐药性的研究.安徽中医学院学报,2000,3:34.

[109] Leung CH,GrillSP, Lam W,etal.Erioea1yxinB Inhibits Nuclear Faetor-{kappa}B Activation by Interfering with the Binding of Both P65 and P5O to the

Response Element in a Noncompetitive Manner.Mol Pharmaeol,2006,6:1946-1955.

[110] 何太平,何振辉,莫丽儿等.半边旗提取物5F影响高转移卵巢癌细胞HO-8910PM细胞周期的实验研究.中药材,2005,.8:672-676.

[111] 何太平,莫丽儿,梁念慈.半边旗提取物5F对HO-89IOPM细胞中NF-kB和FAK蛋白表达的影响.中国药理学通报,2005,5:540-544.

[112] Linda C, Meade-Tollin,EM Kithsiri wijeratne,et al.Ponicidin and oridonin Are Responsible for the Antiangiogenic Aetivity of Rabdosia rubescens, a Constituent of the Herbal Supplement PC SPES.J Nat Prod,2004,67:2-4.

[113]何振辉,何太平,莫丽儿等.白黎芦醇与半边旗二萜类化合物5F对活体血管生成的影响.实用医技杂志,2006,l:1-3.

[114] 曲桂武, 安徽半枝莲中新克罗烷型二萜化合物的发现及抗肿瘤活性研究, 2012, 中国海洋大学. 第 185页.

[115] 袁崇均,王笳,杨红,等.正交试验法优选半枝莲提取工艺的研究[J].华西药学杂志,2002,17(2):112.

因篇幅问题不能全部显示,请点此查看更多更全内容

Copyright © 2019- efsc.cn 版权所有

违法及侵权请联系:TEL:199 1889 7713 E-MAIL:2724546146@qq.com

本站由北京市万商天勤律师事务所王兴未律师提供法律服务